So-called biological dressing effects of cultured epidermal sheets are mediated by the production of EGF family, TGF-β and VEGF

Journal of Dermatological Science

Volumn 32, Issue 3, 2003, Pages 209-215

  Shirakata, Yuji ^a   Tokumaru, Sho ^a   Yamasaki, Kenshi ^a   Sayama, Koji ^a   Hashimoto, Koji ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Biological dressing; Cultured epidermal sheet; EGF family; Keratinocyte; TGF ; VEGF

Indexed keywords

EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ARTICLE; CELL CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS CELL; HUMAN; HUMAN CELL; KERATINOCYTE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; RIBONUCLEASE PROTECTION ASSAY; SKIN GRAFT; WOUND DRESSING; WOUND HEALING;

EID: 0141609049     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(03)00103-8     Document Type: Article

References (38)

1. Eaglstein W.H., Falanga V. Tissue engineering for skin: an update. J. Am. Acad. Dermatol. 39:1998;1007-1010.
2. Phillips T.J. New skin for old: developments in biological skin substitutes. Arch. Dermatol. 134:1998;344-349.
3. Roseeuw D.I., De Coninck A., Lissens W., Kets E., Liebaers I., Vercruysse A., et al. Allogeneic cultured epidermal grafts heal chronic ulcers although they do not remain as proved by DNA analysis. J. Dermatol. Sci. 1:1990;245-252.
4. Phillips T.J., Bhawan J., Leigh I.M., Baum H.J., Gilchrest B.A. Cultured epidermal autografts and allografts: a study of differentiation and allograft survival. J. Am. Acad. Dermatol. 23:1990;189-198.
5. Duinslaeger L., Verbeken G., Reper P., Delaey B., Vanhalle S., Vanderkelen A. Lyophilized keratinocyte cell lysates contain multiple mitogenic activities and stimulate closure of meshed skin autograft-covered burn wounds with efficiency similar to that of fresh allogeneic keratinocyte cultures. Plast. Reconstr. Surg. 98:1996;110-117.
6. McCarthy D.W., Downing M.T., Brigstock D.R., Luquette M.H., Brown K.D., Abad M.S., et al. Production of heparin-binding epidermal growth factor-like growth factor (HB-EGF) at sites of thermal injury in pediatric patients. J. Invest. Dermatol. 106:1996;49-56.
7. Ono I., Gunji H., Zhang J.Z., Maruyama K., Kaneko F. Studies on cytokines related to wound healing in donor site wound fluid. J. Dermatol. Sci. 10:1995;241-245.
8. Tamariz-Dominguez E., Castro-Munozledo F., Kuri-Harcuch W. Growth factors and extracellular matrix proteins during wound healing promoted with frozen cultured sheets of human epidermal keratinocytes. Cell Tissue Res. 307:2002;79-89.
9. Ulubayram K., Nur Cakar A., Korkusuz P., Ertan C., Hasirci N. EGF containing gelatin-based wound dressings. Biomaterials. 22:2001;1345-1356.
10. Cohen M.A., Eaglstein W.H. Recombinant human platelet-derived growth factor gel speeds healing of acute full-thickness punch biopsy wounds. J. Am. Acad. Dermatol. 45:2001;857-862.
11. Fu X., Shen Z., Guo Z., Zhang M., Sheng Z. Healing of chronic cutaneous wounds by topical treatment with basic fibroblast growth factor. Chin. Med. J. (Engl.). 115:2002;331-335.
12. Hashimoto K., Yoshikawa K. The growth regulation of keratinocytes. J. Dermatol. 19:1992;648-651.
13. Hashimoto K. Regulation of keratinocyte function by growth factors. J. Dermatol. Sci. 24:2000;S46-S50.
14. Tokumaru S., Higashiyama S., Endo T., Nakagawa T., Miyagawa J.I., Yamamori K., et al. Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J. Cell. Biol. 151:2000;209-220.
15. Elder J.T., Fisher G.J., Lindquist P.B., Bennett G.L., Pittelkow M.R., Coffey R.J. Jr, et al. Overexpression of transforming growth factor alpha in psoriatic epidermis. Science. 243:1989;811-814.
16. Cook P.W., Mattox P.A., Keeble W.W., Pittelkow M.R., Plowman G.D., Shoyab M., et al. A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin. Mol. Cell. Biol. 11:1991;2547-2557.
17. Hashimoto K., Higashiyama S., Asada H., Hashimura E., Kobayashi T., Sudo K., et al. Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J. Biol. Chem. 269:1994;20060-20066.
18. Shirakata Y., Komurasaki T., Toyoda H., Hanakawa Y., Yamasaki K., Tokumaru S., et al. Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes. J. Biol. Chem. 275:2000;5748-5753.
19. Miyazono K. TGF-beta signaling by Smad proteins. Cytokine Growth Factor Rev. 11:2000;15-22.
20. Detmar M. The role of VEGF and thrombospondins in skin angiogenesis. J. Dermatol. Sci. 24:(Suppl. 1):2000;S78-S84.
21. Detmar M., Yeo K.T., Nagy J.A., Van de Water L., Brown L.F., Berse B., et al. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J. Invest. Dermatol. 105:1995;44-50.
22. Rheinwald J.G., Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell. 6:1975;331-343.
23. Cuono C., Langdon R., McGuire J. Use of cultured epidermal autografts and dermal allografts as skin replacement after burn injury. Lancet. 1:1986;1123-1124.
24. Gallico III G.G., O'Connor N.E., Compton C.C., Remensnyder J.P., Kehinde O., Green H. Cultured epithelial autografts for giant congenital nevi. Plast. Reconstr. Surg. 84:1989;1-9.
25. Mizutani H., Shirakata Y., Adachi A., Hashimoto K., Shimizu M. Cultured epidermal-sheet graft for epidermodysplasia verruciformis. Lancet. 352:1998;709.
26. Carter D.M., Lin A.N., Varghese M.C., Caldwell D., Pratt L.A., Eisinger M. Treatment of junctional epidermolysis bullosa with epidermal autografts. J. Am. Acad. Dermatol. 17:1987;246-250.
27. Hill J.C., Grimwood R.E., Parsons D.S. Treatment of chronic erosions of junctional epidermolysis bullosa with human epidermal allografts. J. Dermatol. Surg. Oncol. 18:1992;396-400.
28. Roseeuw D., De Raeve L., Dangoisse C., Ramet J. Treatment of epidermolysis bullosa with human cultured epidermal allografts. Dermatology. 189:1994;68-70.
29. Campiglio G.L., Pajardi G., Rafanelli G. A new protocol for the treatment of hand deformities in recessive dystrophic epidermolysis bullosa (13 cases). Ann. Chir. Main. Memb. Super. 16:1997;91-100. discussion 101.
30. Lauer G., Sollberg S., Cole M., Flamme I., Sturzebecher J., Mann K., et al. Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. J. Invest. Dermatol. 115:2000;12-18.
31. Elcin Y.M., Dixit V., Gitnick G. Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: implications for tissue engineering and wound healing. Artif. Organs. 25:2001;558-565.
32. Robson M.C., Phillips L.G., Lawrence W.T., Bishop J.B., Youngerman J.S., Hayward P.G., et al. The safety and effect of topically applied recombinant basic fibroblast growth factor on the healing of chronic pressure sores. Ann. Surg. 216:1992;401-406. discussion 406-408.
33. Richard J.L., Parer-Richard C., Daures J.P., Clouet S., Vannereau D., Bringer J., et al. Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study. Diabetes Care. 18:1995;64-69.
34. Setoguchi Y., Jaffe H.A., Danel C., Crystal R.G. Ex vivo and in vivo gene transfer to the skin using replication-deficient recombinant adenovirus vectors. J. Invest. Dermatol. 102:1994;415-421.
35. Ghazizadeh S., Taichman L.B. Virus-mediated gene transfer for cutaneous gene therapy. Hum. Gene Ther. 11:2000;2247-2251.
36. Sawamura D., Akiyama M., Shimizu H. Direct injection of naked DNA and cytokine transgene expression: implications for keratinocyte gene therapy. Clin. Exp. Dermatol. 27:2002;480-484.
37. Meng X., Sawamura D., Tamai K., Hanada K., Ishida H., Hashimoto I. Keratinocyte gene therapy for systemic diseases, Circulating interleukin 10 released from gene-transferred keratinocytes inhibits contact hypersensitivity at distant areas of the skin. J. Clin. Invest. 101:1998;1462-1467.
38. Meng X., Sawamura D., Ina S., Tamai K., Hanada K., Hashimoto I. Keratinocyte gene therapy: cytokine gene expression in local keratinocytes and in circulation by introducing cytokine genes into skin. Exp. Dermatol. 11:2002;456-461.